Bio­gen is pur­su­ing more deal­mak­ing this year, with plans to spend up to $8B

Bio­gen ap­pears to be sub­tly sig­nal­ing it has a larg­er ap­petite for M&A than pre­vi­ous­ly stat­ed.

In an ex­clu­sive in­ter­view with End­points News, Bio­gen head …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER